London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Look at eton share price today we got well shafted,
Record sales of ALKINDI SPRINKLE. ALKINDI SPRINKLE saw another record revenue quarter. The Company’s goal is to reach 400 active patients by the end of the year.
( D ) Did have it when ticker searched .
NDQ | NBIX | US64125C1099 | USD
Placed low GTC order but was near there 26 October 2022.
Near recent highs of $124 now
28th October 2022
Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Allots and issues a total of 4.8 million new ordinary shares of 5 pence each in Diurnal. This follows the court sanctioning the scheme in relation to the recommended cash offer by Neurocrine Biosciences Inc.
Thinking of buying Neurocrine Biosciences, Inc.
( D ) Only has the trdegate euro ones on platform .
From Motley . 11th October 2022.
Neurocrine Biosciences (NBIX -1.45%) stands out as another biotech stock that's trouncing the market. Its shares have jumped more than 25% year to date. Since early May, Neurocrine stock has soared over 40%.
Current Price
$121.44
The company's tardive dyskinesia drug Ingrezza continues to enjoy strong momentum, with sales rising 30% year over year in the second quarter of 2022. Neurocrine even raised its full-year sales guidance for the drug to a range of $1.35 billion to $1.4 billion from its previous forecast of sales between $1.25 billion and $1.35 billion.
Everything hasn't gone Neurocrine's way this year, though. In August, the company reported disappointing results from a phase 2a clinical study evaluating NBI-827104 in treating the neurological disorder essential tremor. After the study failed to meet its endpoints, Neurocrine decided to throw in the towel on any further development of NBI-827104.
However, Neurocrine has plenty of catalysts on the way. It hopes to file for U.S. approval later this year for Ingrezza in treating a second indication -- chorea in Huntington's disease. Results from a late-stage study of the drug in treating schizophrenia are expected next year. The company also expects to report registration data in 2023 from clinical studies evaluating experimental drug crinecerfont in treating the genetic disorder congenital adrenal hyperplasia in adults and in children.
Monies in account today a loss of 57% after 3 buys . ( 300 % in )
Looked up the history again before seeing 30 August 2022 post below here , first buy 28/10/20 , then April and May 2021 after another 20m placing raise
I must of let the OO that came with the last placing pass , as no sign of it .
Yep shafted!!!
Yes very painful.
Good bb input Daveboy cheers.
Better luck on the next…….
A.
Ah well, it's official - we've been shafted !
Should be ashamed of themselves this BOD.
Good luck to all for the future.
That decision by NHS Wales reported in 7th October about Efmody approval for use. Ouch.
Makes you wonder if Scots NHS working for bidder...of course not. just seems that way.
88k against
Me too fwiw, 130,000
Against, fwiw.
45,000 - GLA.
Kind thanks nopolus and Woodstock all the best
Perhaps that's why Whitaker departed as well - protested too much ...
Still got all his freebies before departure of course.
Whole thing stinks bad.
Nopulus. Was window shopping and saw your post.
Just posting to say hello to you.
Warm regards.
I agree with your point of view that the LT holders have been badly done by ..
I just hope some white knight will come out of the blue
Not sure how to think about an offer for 27.5p as will be a big loss .
On the other hand only worth 11p last week .
After two placings at 60p and 70p shortly before bought these 28/10/20 @ 59p 29/4/21 @ 68p 17/621 @ 66p .
Massive fall here in November 2018 from 200p to 28p .
They went for placings at to peaks in share price .
IP Group PLC own 30% .. quite a few hedge funds and instinctual fund managers .
so they make a pointless comment about finances and funding for no reason whatsoever. I've never known a company on AIM do that. They always announce the placing and then it's done they never scare the market to crash the stock. Then low and behold months after there's an offer just at the right time the VWA is low killing all the PI's who were in for the long hall. I think a complaint to the FCA is warranted.
We can but hope.
Yep, same here for what it's worth.
Against.
I'll vote against this too.
I nearly bought more recently as well, but was put off by the potental placing. Gutted. I'm sat with an average of 60p, a hefty loss. Not a large holding but annoying all the same. I'll be voting against this, not that it will make any difference. I'm really hacked off by the BOD, they've properly shafted shareholders here but will no doubt get a nice payout
We could hope for Eton to get involved - counter offer?
Goodness - I had 390k shares all bought at much higher price and thought that was a lot - maybe a chance to hit 26% if those who believed in the future here all vote against this - happens over and over again on AIM - as ever thought this group were different